non small cell lung cancer
Showing 1 - 25 of 663
Non Small Cell Lung Cancer Trial in France (Paclitaxel, Bevacizumab, Atezolizumab)
Not yet recruiting
- Non Small Cell Lung Cancer
- Paclitaxel
- +2 more
-
Amiens, France
- +42 more
Mar 10, 2023
Advanced Cancer, Non Small Cell Lung Cancer Trial (Tepotinib, Pembrolizumab)
Not yet recruiting
- Advanced Cancer
- Non Small Cell Lung Cancer
- (no location specified)
Mar 13, 2023
Genetic and Epigenetic Factors on Clinical Response and Toxicity
Recruiting
- Non Small Cell Lung Cancer
- +2 more
- Cisplatin injection
-
Cairo, EgyptAin Shams University
Feb 16, 2023
Non Small Cell Lung Cancer Trial in Worldwide (IPH5201 + durvalumab + standard chemo)
Recruiting
- Non Small Cell Lung Cancer
- IPH5201 + durvalumab + standard chemotherapy
-
Tampa, Florida
- +23 more
Feb 23, 2023
Cancer Pain, Non Small Cell Lung Cancer, Bone Metastases Trial (Transcutaneous electrical acupoint stimulation, Sham
Not yet recruiting
- Cancer Pain
- +3 more
- Transcutaneous electrical acupoint stimulation
- +2 more
- (no location specified)
Feb 17, 2023
Responsiveness in Oncology Patients Based on Host Response
Recruiting
- Non Small Cell Lung Cancer
- Healthy
- blood, stool and tissue samples collection
-
Dallas, TexasBaylor Scott and White Research Institute
Feb 9, 2023
Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +15 more
- A2B530
- xT-Onco with HLA-LOH Assay
-
Duarte, California
- +6 more
Feb 10, 2023
Advanced Cancer, Advanced Solid Tumor, Tumor Malignant Trial in United Kingdom (Fosifloxuridine Nafalbenamide, Leucovorin,
Not yet recruiting
- Advanced Cancer
- +16 more
- Fosifloxuridine Nafalbenamide
- +3 more
-
Birmingham, United Kingdom
- +3 more
Feb 1, 2023
Non Small Cell Lung Cancer Trial (Tislelizumab, Ociperlimab, LBL-007)
Not yet recruiting
- Non Small Cell Lung Cancer
- Tislelizumab
- +2 more
- (no location specified)
Jan 30, 2023
Determine Pro-Inflammatory Cytokine Kinetics During Immune
Not yet recruiting
- Non Small Cell Lung Cancer
- Melanoma
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
Jan 30, 2023
Non Small Cell Lung Cancer Trial (Navtemadlin, Navtemadlin Placebo, Pembrolizumab)
Not yet recruiting
- Non Small Cell Lung Cancer
- Navtemadlin
- +2 more
- (no location specified)
Jan 27, 2023
Cancer, Solid Tumor, Colorectal Cancer Trial (biological, radiation, drug)
Not yet recruiting
- Cancer
- +8 more
- DK210 (EGFR)
- +3 more
- (no location specified)
Jan 27, 2023
Solid Tumor, Non Small Cell Lung Cancer, Melanoma Trial in Lafayette, Boston, Nashville (AB248, Pembrolizumab)
Recruiting
- Solid Tumor
- +4 more
- AB248
- Pembrolizumab
-
Lafayette, Indiana
- +2 more
Jan 25, 2023
Non Small Cell Lung Cancer, EGFR Gene Mutation, Immune Checkpoint Inhibitor Trial in Jerusalem (concomitant TTFields treatment
Not yet recruiting
- Non Small Cell Lung Cancer
- +2 more
- concomitant TTFields treatment device to standard of care EGFR positive NSCLC treatment
- concomitant TTFields treatment device to standard of care anti PD-1 NSCLC treatment
-
Jerusalem, IsraelShaare Zedek Medical Center
Jan 22, 2023
Brain Metastases, Adult, Non Small Cell Lung Cancer, Breast Cancer Trial in Messina, Rome, Turin (Silibinin, Placebo)
Recruiting
- Brain Metastases, Adult
- +2 more
- Silibinin
- Placebo
-
Messina, Italy
- +4 more
Jan 9, 2023
Non Small Cell Lung Cancer, Metastatic NSCLC, Recurrent Non Small Cell Lung Cancer Trial (Pembrolizumab, GT103)
Not yet recruiting
- Non Small Cell Lung Cancer
- +2 more
- (no location specified)
Jan 12, 2023
Non Small Cell Lung Cancer, Stage IV NSCLC, Recurrent Non Small Cell Lung Cancer Trial in Tampa (biological, drug, other)
Recruiting
- Non Small Cell Lung Cancer
- +2 more
- Tumor-infiltrating Lymphocytes (TIL)
- +5 more
-
Tampa, FloridaMoffitt Cancer Center
Dec 28, 2022
Non Small Cell Lung Cancer Trial in Pittsburgh (Fecal Microbiota Transplant (FMT), Pembrolizumab)
Not yet recruiting
- Non Small Cell Lung Cancer
- Fecal Microbiota Transplant (FMT)
- Pembrolizumab
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Dec 20, 2022
Whole Blood From Active Non-Small Cell Lung Cancer Supplemental
Recruiting
- Non Small Cell Lung Cancer
- Specimen sample
-
Waltham, MassachusettsSanguine Biosciences
Dec 28, 2022
Non Small Cell Lung Cancer Trial (Ensartinib Hydrochloride)
Not yet recruiting
- Non Small Cell Lung Cancer
- Ensartinib Hydrochloride
- (no location specified)
Dec 15, 2022
Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Non-small Cell Carcinoma Trial in United States (radiation,
Recruiting
- Non Small Cell Lung Cancer
- +4 more
- L-SABR
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Dec 20, 2022